JP2022551066A5 - - Google Patents

Info

Publication number
JP2022551066A5
JP2022551066A5 JP2022520062A JP2022520062A JP2022551066A5 JP 2022551066 A5 JP2022551066 A5 JP 2022551066A5 JP 2022520062 A JP2022520062 A JP 2022520062A JP 2022520062 A JP2022520062 A JP 2022520062A JP 2022551066 A5 JP2022551066 A5 JP 2022551066A5
Authority
JP
Japan
Prior art keywords
methyl
dihydroxy
biphenyl
pentyl
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022520062A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022551066A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CA2020/051330 external-priority patent/WO2021062559A1/en
Publication of JP2022551066A publication Critical patent/JP2022551066A/ja
Publication of JP2022551066A5 publication Critical patent/JP2022551066A5/ja
Pending legal-status Critical Current

Links

JP2022520062A 2019-10-02 2020-10-02 カンナビノイド誘導体 Pending JP2022551066A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201962909363P 2019-10-02 2019-10-02
US62/909,363 2019-10-02
US202062966418P 2020-01-27 2020-01-27
US62/966,418 2020-01-27
PCT/CA2020/051330 WO2021062559A1 (en) 2019-10-02 2020-10-02 Cannabinoid derivatives

Publications (2)

Publication Number Publication Date
JP2022551066A JP2022551066A (ja) 2022-12-07
JP2022551066A5 true JP2022551066A5 (enExample) 2023-10-11

Family

ID=75336687

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022520062A Pending JP2022551066A (ja) 2019-10-02 2020-10-02 カンナビノイド誘導体

Country Status (4)

Country Link
US (1) US12325709B2 (enExample)
EP (1) EP4037676A4 (enExample)
JP (1) JP2022551066A (enExample)
WO (1) WO2021062559A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021007663A1 (en) 2019-07-12 2021-01-21 Canopy Growth Corporation Cannabinoid derivatives
JP2022540586A (ja) 2019-07-12 2022-09-16 キャノピー グロウス コーポレイション カンナビノイド誘導体
US12252503B2 (en) 2019-07-12 2025-03-18 Canopy Growth Corporation Cannabinoid derivatives
WO2021102567A1 (en) 2019-11-26 2021-06-03 Canopy Growth Corporation Cannabigerol derivatives and use thereof as cannabinoid receptor modulators
US12240813B2 (en) 2020-05-19 2025-03-04 Cybin Irl Limited Deuterated tryptamine derivatives and methods of use
CN114507153B (zh) * 2020-11-17 2025-06-24 中国科学院上海药物研究所 一类间苯二酚化合物及其制备方法以及在神经系统疾病中的应用
US20250019345A1 (en) * 2021-11-10 2025-01-16 London Pharmaceuticals And Research Corporation New cannabinoid-gabapentinoid conjugates and uses thereof
GB2644507A (en) * 2023-05-11 2026-04-15 Council Of Scient And Industrial Research An Indian Registered Body Incorporated Under The Regn Of S 2'-{heterocyclyl (aryl/alkyl) methyl}-cannabidiol compounds and process for preparation thereof

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9814789A (pt) * 1997-08-26 2000-10-10 Kumiai Chemical Industry Co Derivados de ácido biarilalquilenocarbamânico e fungicidas agrìcolas e hortìcolas
US7285687B2 (en) * 2002-04-25 2007-10-23 Virginia Commonwealth University Cannabinoids
ATE413167T1 (de) 2004-08-17 2008-11-15 Galderma Res & Dev Neuartige biaromatische ppar-rezeptoren aktivierende zusammensetzungen und ihre verwendung in kosmetischen oder pharmazeutischen zusammensetzungen
WO2010096650A1 (en) 2009-02-20 2010-08-26 University Of Kansas Novobiocin analogues having modified sugar moieties
WO2008021849A2 (en) 2006-08-09 2008-02-21 Smithkline Beecham Corporation Novel compounds as antagonists or inverse agonists at opioid receptors
WO2008096769A1 (ja) * 2007-02-08 2008-08-14 Daiichi Sankyo Company, Limited 置換されたセルコスポラミド誘導体を含有する医薬
PT2303270T (pt) * 2008-05-05 2017-08-25 Sanofi Sa Derivados fundidos do ácido ciclopentanocarboxílico substituídos por acilamino e sua utilização como produtos farmacêuticos
US9254272B2 (en) * 2011-11-30 2016-02-09 Sutter West Bay Hospitals Resorcinol derivatives
WO2014062965A1 (en) * 2012-10-17 2014-04-24 Northeastern University 2-cycloalkyl resorcinol cannabinergic ligands
EP2762134A1 (en) * 2013-02-04 2014-08-06 Bioversys AG Composition for treatment of pathogens that are resistant to tetracyclines
KR20160036568A (ko) * 2013-07-18 2016-04-04 노파르티스 아게 보체 인자 d 억제제로서의 아미노메틸-비아릴 유도체 및 그의 용도
EP2842933B1 (de) * 2013-09-03 2015-07-29 Symrise AG Mischungen cannabinoider Verbindungen, deren Herstellung und Verwendung
EP3226847A2 (en) * 2014-12-04 2017-10-11 Servicio Andaluz De Salud Use of cannabinoids as ceramide-generating anticancer agents in tumors of the hematopoietic and lymphoid tissues
US9717683B1 (en) * 2016-06-29 2017-08-01 Ep Pharma, Llc Low-temperature inhalation administration of cannabinoid entities
PE20190654A1 (es) * 2016-08-18 2019-05-08 Canopy Growth Corp Plantas y metodos para aumentar y disminuir la sintesis de cannabinoides
US10640482B2 (en) * 2017-07-21 2020-05-05 University Of South Florida Synthesis of cannabinoids
WO2019234728A1 (en) * 2018-06-04 2019-12-12 Al&Am Pharmachem Ltd. Cannabinolic acid derivatives and uses thereof
EP3847154A1 (en) 2018-09-03 2021-07-14 F. Hoffmann-La Roche AG Carboxamide and sulfonamide derivatives useful as tead modulators
CA3128712A1 (en) 2018-11-30 2020-06-04 Canopy Growth Corporation Water-soluble formulations of cannabinoids or cannabis-derived compounds, methods of making and use
EP3886910A4 (en) 2018-11-30 2022-07-27 Canopy Growth Corporation A CANNABINOID OR A CANNABIS-CONTAINING COMPOUND, PROCESS FOR THEIR PRODUCTION AND THEIR USE
WO2020198874A1 (en) * 2019-04-04 2020-10-08 Scf Pharma Inc. Cannabidiolic acid monoglycerides, derivatives, and uses thereof
EP3994114A4 (en) 2019-07-04 2023-08-16 Canopy Growth Corporation CANNABINOID DERIVATIVES
WO2021000054A1 (en) 2019-07-04 2021-01-07 Canopy Growth Corporation Cannabinoid derivatives
WO2021007663A1 (en) 2019-07-12 2021-01-21 Canopy Growth Corporation Cannabinoid derivatives
JP2022540586A (ja) 2019-07-12 2022-09-16 キャノピー グロウス コーポレイション カンナビノイド誘導体
EP3997095B1 (en) 2019-07-12 2025-02-12 Canopy Growth Corporation Cannabinoid derivatives
US12252503B2 (en) 2019-07-12 2025-03-18 Canopy Growth Corporation Cannabinoid derivatives
WO2021007659A1 (en) 2019-07-12 2021-01-21 Canopy Growth Corporation Cannabinoid derivatives
WO2021062557A1 (en) 2019-10-02 2021-04-08 Canopy Growth Corporation Cannabinoid derivatives
US20230286906A1 (en) 2019-11-26 2023-09-14 Canopy Growth Corporation Cannabinoid derivatives
EP4065568A4 (en) 2019-11-26 2024-01-03 Canopy Growth Corporation CANNABINOIDS DERIVATIVES
WO2021102567A1 (en) 2019-11-26 2021-06-03 Canopy Growth Corporation Cannabigerol derivatives and use thereof as cannabinoid receptor modulators
WO2021113958A1 (en) 2019-12-09 2021-06-17 Canopy Growth Corporation Cannabinoid derivatives

Similar Documents

Publication Publication Date Title
JP2022551066A5 (enExample)
JP2022551067A5 (enExample)
JP2022540434A5 (enExample)
JP2023503330A5 (enExample)
JP2022539400A5 (enExample)
JP2023503601A5 (enExample)
JP7642707B2 (ja) カルバモイルフェニルアラニノール類縁体およびその使用
ES2313391T3 (es) 1,1a,5,5a-tetrahidro-3-tia-ciclopropa(a)pentalenos: derivados de tiofeno triciclico como agonistas del receptor s1p1/edg1.
SK284068B6 (sk) Ester odvodený od substituovanej fenylcyklohexylovej zlúčeniny, spôsob jeho prípravy a použitie
US7741355B2 (en) Small-molecule modulators of TRP-p8 activity
JP2022540432A5 (enExample)
RU2012120387A (ru) Замещенные производные 4-аминоциклогексана
JP2013507374A (ja) Ｇタンパク質共役受容体８８の修飾因子
RU2008144415A (ru) Композиции, полезные в качестве ингибиторов потенциалзависимых натриевых каналов
AR074184A1 (es) Compuestos de 7-azaspiro[3.5]nonano-7-carboxamida, composiciones farmaceuticas que los comprenden y su uso en la fabricacion de medicamentos para el tratamiento de afecciones mediadas por la inhibicion de faah
RU2012129737A (ru) Замещенные бензамидные производные
RU2015149528A (ru) 2-фенилимидазо[1,2-а]пиримидины в качестве визуализирующих средств
JP2008013556A (ja) 新規ナフタレン化合物、その製造法、およびそれを含有する薬学的組成物
EP2888239B1 (en) Reduced central corneal thickening by use of hydrophilic ester prodrugs of beta-chlorocyclopentanes
US6566554B1 (en) Aminobenzophenones as inhibitors of IL-1β and TNF-α
JP2021515004A5 (enExample)
JP2022540586A5 (enExample)
CA2716961A1 (fr) Composes derives d'azetidines, leur preparation et leur application en therapeutique
FR2843964A1 (fr) Derives de dioxane-2-alkylcarbamates, leur preparation et leur application en therapeutique
CN101115728B (zh) 三唑取代的氨基二苯甲酮化合物